Otu esi nyefee Peptides emebere AI na CDMO: Akwụkwọ egwuregwu Handoff

Otu esi nyefee Peptides emebere AI na CDMO: Akwụkwọ egwuregwu Handoff

Ọgụgụ isi nke okike agbanweela nchọpụta de novo peptide n'ụzọ bụ isi. Eserese mmụta dị omimi - sitere na RFdiffusion na ProteinMPNN ruo AlphaFold3 na ESM3 - na-ewepụta ọtụtụ iri puku ndị ntinye akwụkwọ n'usoro n'ime nkeji.. Agbanyeghị, obere ọkpọ na-adịgide adịgide na-eyi ọkpọkọ nchọpụta ọgwụ mgbako egwu: nke AI-na-oche aka aka.

Ụdị mgbakọ na mwepụ na-enyocha peptide site na geometry ọkpụkpụ azụ, ike njikota buru amụma, na ntụkwasị obi nhazi. Òtù Mmepe na Nrụpụta Nkwekọrịta (CDMO), n'ụzọ dị iche, na-enyocha otu usoro ahụ site na kemistri siri ike, ihe mgbaze, na-echebe otu kinetics, na-amịpụta ọcha. Mgbe a na-ebufe ihe ngụkọ na CDMO dị ka eriri ederede FASTA doro anya na-enweghị ọnọdụ anụ ahụ, Nkwekọrịta ọdịda na-arị elu nke ukwuu.

Ihe na-adịbeghị anya GenScript na Tamarind Bio mmekorita na-egosipụta nnukwu mgbanwe ụlọ ọrụ: ijikọ nyiwe imewe AI dabere na ígwé ojii ozugbo na ọrụ nkwado ụlọ nyocha ewepụtara. Ijikọ Tamarind Bio's suite nke ụdị ihe eji eme ihe n'ime Tamarind Assay Portal na ikike ụlọ nyocha akpaka nke GenScript na-ewepụta ụkpụrụ maka usoro ọrụ dijitalụ na nke anụ ahụ..

Iji nweta nnukwu ego na njikọ a na-akpaghị aka, biotech R&D otu, ndị isi nyocha, na ndị na-ahụ maka chemist chọrọ usoro nrubeisi ahaziri ahazi. Akwụkwọ egwuregwu a na-akọwapụta ihe achọrọ teknụzụ, tupu njikọ na silico nzacha, ọdịda-ụdị mbelata, yana nnwale nkwado dị mkpa iji wepụ ihe ize ndụ AI-haziri usoro peptide n'aka ndị mmekọ CDMO..

1. Na-agafe faịlụ FASTA: Metadata ntinye CDMO dị mkpa

Na-enyefe eriri amino acid ahịrị dị mfe (eg., ACDEFGHIKLMNPQRSTVWY) na CDMO bụ isi ihe na-ebute oge nhazi oge na ọdịda nyocha na-atụghị anya ya. Ụdị mmepụta ihe na-ewebatakarị topologies ọkpụkpụ azụ pụrụ iche, nnukwu hydrophobic patches, ma ọ bụ njikọta disulfide na-abụghị nke ala nke ọkọlọtọ peptide siri ike na-agbakọ (SPSS) protocol enweghị ike ijikwa ya na-akpaghị aka.

Iji hụ na ntụgharị asụsụ kemịkalụ ziri ezi, ngwugwu nrubeisi zuru oke ga-enwerịrị ogidi metadata anọ dị iche iche.

Ihe nrụpụta AI Design (PDB / JSON)

1. Imepụta Provenance & Ihe Nlereanya (Nlereanya ije, mkpụrụ, pLDDT, pAE)
2. Metriks ngụkọ (Njikọ ΔG, UGBUA, Ike ngwọta)
3. Chemical & Ihe mgbochi ihe owuwu (N/C mkpuchi, Ịgba ígwè, AA na-abụghị nke canonical)
4. Nkọwapụta ebumnuche & Jiri Okwu (Ịdị ọcha ≥98%, Ọnụọgụ, Ihe achọrọ adịghị mma) Ngwungwu usoro ọrụ CDMO ahaziri ahazi

Ọgwụ 1: Imepụta Provenance na Generative Context

Ndị injinia synthesis CDMO kwesịrị ịghọta ka esi emepụta usoro a. Ngosipụta ihe nlere anya na-ekpughe echiche nhazi dị n'ime:

• Model Architecture na ụdị: Kọwaa ma usoro a sitere na RFdiffusion, AlphaFold-Multimer, ProteinMPNN, ESMfold, ma ọ bụ ihe nlereanya ensemble.
• Parameters ọgbọ: Dekọọ ọnụọgụ mkpụrụ na-enweghị usoro, ntọala okpomọkụ, na imewe biases (eg., mmanye hydrophobic interface mbukota).
• Akara ntụkwasị obi nke fọduru kwa: Gụnye pLDDT mpaghara (Nnwale Ọdịiche Mpaghara buru amụma) akara gafee usoro. Usoro nwere mpaghara pLDDT dị ala (< 70) na-adakọkarị na loops na-agbanwe agbanwe ma ọ bụ akụkụ ndị na-emeghe na-akpa àgwà na-enweghị atụ n'oge a na-asachapụ.

Ọgwụ 2: Metriks ngụkọ

• Mperi ejikọtara ọnụ (pAE): Nye ụkpụrụ pAE interface maka peptides na-ejikọta ebumnuche iji gosipụta ihe fọdụrụ na kọntaktị dị mkpa.
• Ejikọtara ike efu (ΔG): Gụnye akara eletrọstatic gbakọọ na van der Waals interface.
• Ebe mgbaze nwere ike ịnweta (UGBUA): Nkọwa hydrophobic vs. polar elu mkpughe.

Ọgwụ 3: Ihe mgbochi kemịkalụ na nhazi

• Mgbanwe ọnụ ọnụ: Kọwaa n'ụzọ doro anya capping N-terminal (eg., free amine, Actylation, Pyroglutamate) na C-terminal capping (eg., free acid, Amidation).
• Ihe owuwu cyclization: Kwupụta kpọmkwem njikọ atọm maka peptides cyclic — njikọ amide isi na ọdụ, akụkụ-agbụ gaa n'akụkụ-agbụ lactam àkwà mmiri, ma ọ bụ kpọmkwem cysteine ​​disulfide ụzọ abụọ.
• Ihe fọdụrụ na-abụghị nke Canonical: Gwakọta ihe niile D-amino acid, β-amino acid, N-methylated fọdụrụnụ, ma ọ bụ mgbanwe ntụgharị asụsụ gachara (eg., lipidation, phosphorylation, PEGylation).

Ọgwụ 4: Nkọwapụta ebumnuche yana oke ngwa

• Ọkwa ịdị ọcha achọrọ: Chọọ, ≥85% (nyocha), ≥95% (bioassay nke in vitro), ma ọ bụ ≥98% (dị ndụ / Ọmụmụ ihe na-enyere IND aka).
• Ọnụọgụ ọnụọgụgụ: Ọnụ ọgụgụ milligram (1-10 mg maka nyocha njikọ mbụ) ruo gram/kilogram (pilot n'ichepụta).
• Ihe achọrọ ịmụ nwa: Kọwaa ma ihe a chọrọ imepụta na klaasị 100 gburugburu ime ụlọ dị ọcha iji gbochie endotoxin na mmetọ bioburden n'oge nyocha dabere na cell.

Atụmatụ faịlụ ntinye ahaziri ahazi

Iji kwalite oriri dijitalụ, kwadebe data n'ụdị atọ ahaziri ahazi:

Maka ndụmọdụ: Tinye faịlụ nhazi 3D mgbe niile (.pdb ma ọ bụ .cif) n'akụkụ usoro ahịrị maka peptides cyclic ma ọ bụ multi-disulfide. Ihe nyocha CDMO akpaghị aka na-eji faịlụ 3D kwado maapụ njikọ cysteine ​​tupu nhọrọ resin siri ike..

2. Tupu arụkọ ọrụ n'ime ihe nzacha Silico Triage

Ụdị ndị na-emepụta ihe na-ebuli nke ọma maka mmekọ njikọ ezubere iche. N'ime otú ahụ, ha na-ewepụtakarị usoro na-abụghị nke anụ ahụ nke na-agaghị ekwe omume na kemịkalụ ma ọ bụ nke siri ike ịmekọrịta. Tupu ịnye iwu ịzụrụ ihe, na-agba ọsọ ọsọ site na multi-parameter na silico screening cascade.

Raw AI kụrụ ọdọ mmiri (10,000 Ndị ndoro-ndoro ochichi)

Iyo 1: GRAVY Hydropathicity (-0.5 ka +0.2) Nyefee nzacha 2: Ụgwọ netwọk & pI (|Ụgwọ netwọk| ≥ 2 na pH 7.4) Nyefee nzacha 3: Akara Solubility Intrinsic CamSol (> -1.0) Nyefee nzacha 4: Mkpokọta mkpokọta TANGO β-akwụkwọ (< 5%) Gafe Synthesis-njikere ọdọ mmiri Candidat (100 Mmeri dị elu)

1. GRAVY (Nnukwu nkezi nke Hydropathicity)

Akara GRAVY na-agbakọ nchikota ụkpụrụ hydropathicity nke amino asịd niile na-ekewa site na ogologo usoro..

• Oke kacha mma: -0.5 ka +0.2.
• Oke ihe egwu dị elu: Akara karịrị +0.4 gosi oke hydrophobicity. Ndị peptides ndị a na-agbakọta na resin n'oge SPPS ma na-egosipụta solubility aqueous na-enweghị atụ..

2. Ebe isoelectric (pI) na Net Charge

Peptides na-ebu obere ụgwọ net dị nso pI ha, na-eduga na njikọ onwe onye na mmiri ozuzo.

• Ọchịchị: Gbakọọ ụgwọ net na pH physiological (pH 7.4). Gbaa mbọ hụ na a ga-akwụ ụgwọ net opekata mpe +2 ma ọ bụ -2. Ọ bụrụ na ụgwọ net dị n'etiti -1 na +1 na usoro nwere hydrophobic patches, tinye solubilizing lysine ma ọ bụ glutamates na njedebe na-enweghị njikọ (eg., na-agbakwunye mkpado KDK ma ọ bụ EEE).

3. Akara Solubility Intrinsic CamSol

CamSol na-enyocha hydrophobicity amino acid dị na mpaghara, ebubo, na ihe owuwu nke abụọ.

• Ọnụ ụzọ: Ọnụ ọgụgụ dị mma na-egosi oke solubility dị n'ime. Usoro na-enye akara n'okpuru -1.0 kwesịrị ka egosi ya maka njikarịcha usoro ma ọ bụ aka pụrụ iche solubilizing.

4. Mkpokọta TANGO

TANGO na-agbakọ ike nke akụkụ peptide agbasaghị agbasa iji mepụta mkpokọta β-sheet intermolecular..

• Ọnụ ụzọ: Akụkụ usoro ọ bụla na-egosi akara nchịkọta TANGO > 5% na-anọchi anya nnukwu ihe egwu maka nchịkọta on-resin n'oge elongation yinye.

5. Usoro Motif nyocha

Tọọ ọkọlọtọ ma gbanwee ụkpụrụ usoro nsogbu tupu nrubeisi:

• Hydrophobic na-agba ọsọ: $> 3$ consecutive hydrophobic residues (eg., Ụlọ ọrụ njem nleta, LLL, FIW, IYF) kpalite mkpokọ akwụkwọ β ngwa ngwa.
• Aspartimide-dịkarịa ala dipeptides: DG, DS, NA, na DN motifs n'okpuru isi ọnọdụ nchebe Fmoc na-enweta cyclization nke n'akụkụ iji mepụta ngwaahịa aspartimide..
• Otutu ụyọkọ Cysteine ​​​​nwere: Cysteine ​​​​na-enweghị nchebe kewapụrụ site na obere karịa 2 amino asịd na-akpaghasị mkpochapụ otu nchekwa nhọrọ.

Framework nyocha nke tupu synthesis ọnụọgụ

3. Mpaghara ihe egwu dị egwu: Ebe AI Peptide kụrụ dara na bench

Mgbu nke sịntetik na-atụgharị ụdị dijitalụ ka ọ bụrụ ihe anụ ahụ. Ịghọta kemistri anụ ahụ dị n'okpuru nke SPPS na-enye ohere R&Ndị otu D ga-atụ anya mkpọmkpọ CDMO ma kwalite atụmatụ mbelata ihe egwu.

Ntugharị igodo: gafere 70% nke AI-mepụtara peptide njikọ ọdịda ọdịda sitere na on-resin inter-chain aggregation.. Modeldị ndị na-emepụta ihe n'elu-index na nkwakọ ngwaahịa hydrophobic iji bulie ike njide buru amụma, n'amaghị ama na-emepụta usoro nke na-agbakọta onwe ya n'ime mpempe akwụkwọ β-adịghị ike n'oge nhazi usoro siri ike..

Ihe ize ndụ 1: Mkpokọta on-resin na njikọ na-ezughị ezu

N'oge SPPS, Agbụ peptide na-eto eto jikọtara na resin nkwado siri ike nwere ike ịmalite n'etiti- na intramolecular hydrogen-boded β-ibé akwụkwọ. Dị ka na-adịbeghị anya on-resin β-akwụkwọ nchịkọta ọmụmụ, Ngwakọta amino acid hydrophobic na-eme ka usoro nke abụọ daa n'ime pores resin ozugbo.

Nchịkọta a na-egbochi ọzịza ihe mgbaze ma gbochie piperidine reagent ịbanye na otu N-terminal Fmoc. N'ihi ya:

1. Fmoc Deprotection Kinetics na-agbada: Usoro nchebe na-emekarị 3 nkeji gbatịa ruo 30+ nkeji ma ọ bụ daa akụkụ ụfọdụ.
2. Usoro nhichapụ na-agbakọta: Otu amino anaghị emeghachi omume na-adị n'oge usoro njikọta na-esote, na-enye ngwakọta dị mgbagwoju anya nke N-1 na N-2 adịghị ọcha nhichapụ nke ọ fọrọ nke nta ka ọ bụrụ ihe na-agaghị ekwe omume ikewa site na ntụgharị-phase HPLC.

Nyochaa Bench: Na njikọ dị elu na-arụ ọrụ na-agba ọsọ nke ndị na-emepụta ihe na-emepụta AI na-agbatị hydrophobic (>3 consecutive hydrophobic residues), ezigbo oge Fmoc deprotection UV nlekota na-egosipụtakarị mbelata arụmọrụ dị elu mgbe ihe fọdụrụ 8-12 gasịrị.. Ịgbakwunye pseudoproline dipeptides n'ọnọdụ ndị a na-eweghachi kinetics mmeghachi omume ndabere ma na-ewepụ adịghị ọcha nke mkpochapụ..

Steeti Resin gbakọtara:

[Resin Bead] (Hydrophobic β-Ibe mpempe akwụkwọ) Fmoc-Amine (Egbochiri) x (Piperidine enweghị ike ịnweta)

edoziziri / Steeti mebiri emebi:

[Resin Bead] [Pseudoproline / Isoacyl njikwa] Fmoc-Amine (Ekpughere) ► (Nchedo zuru oke)

Ihe ize ndụ 2: Ịgba ọsọ n'oge njikọta

Ụdị Generative AI anaghị agụta maka nkwụsi ike stereochemical n'oge arụ ọrụ. SPPS na-enyere aka n'igwe ọkụ dị elu na-eme ka mmeghachi omume njikọ dị ngwa ngwa mana ọ na-abawanye ihe egwu ịgba ọsọ maka amino acid dị iche iche.:

• Cystine: Ọ na-enwekarị ike ịnweta α-carbon racemization base-catalyzed site na enolization n'oge ọrụ carbodiimide..
• Histidine: Agbụ akụkụ imidazole na-enweta catalysis intramolecular base, na-eduga na L-to-D stereoisomerization.
• Aspartate: Nkwalite mgbasa ozi nke ntọala na-akwalite nguzobe D-aspartate n'akụkụ nhazigharị aspartimide..

Ihe ize ndụ 3: Mmeghachi omume akụkụ na mkpochapụ TFA

Nchedo zuru ụwa ọnụ site na iji Trifluoroacetic Acid (TFA) na-atọhapụ carbocation reactive n'aka otu ndị na-echebe agbụ akụkụ (eg., tBu, Trt, Pbf). N'usoro bara ụba na Tryptophan, Tyrosine, ma ọ bụ methionine:

• Carbocation efu na-ejikọ ọzọ na mgbanaka indole nke Trp ma ọ bụ thioether nke Met.
• Cocktails scavenger ezughi oke (EDT, TIS, mmiri, phenol) na-eduga na ngwaahịa akụkụ alkylated na-adịghị agbanwe agbanwe nke na-emerụ ngwaahịa ikpeazụ.

Ihe ize ndụ 4: Njikọta Disulfide na Oxidation Ambiguity

De novo peptides ejiri rụọ ya 2, 4, ma ọ bụ 6 Mwepu cysteine ​​na-eweta nnukwu nsogbu mpịachi. oxidation ikuku na-achịkwaghị achịkwa nke peptide 4-cysteine ​​​​nwere ike imepụta regioisomers disulfide atọ dị iche iche.:

Yiri (Cys_1-Cys_2, Cys_3-Cys_4) vs. Mgbochi Parallel (Cys_1-Cys_4, Cys_2-Cys_3) vs. Ejikọtara ọnụ (Cys_1-Cys_3, Cys_2-Cys_4)

Ọ bụrụ na ụdị AI na-ewere otu n'ogige atụrụ, ikuku oxidation dị mfe na DMSO/mmiri na-ebutekarị isomers topological ma ọ bụ soluble oligomers..

Ihe ize ndụ 5: Analytical ambiguity in Reverse-phase HPLC

Hydrophobic AI hits na-enyekarị ohere sara mbara, Kewaa, ma ọ bụ ogologo ọdụ ọdụ na kọlụm nyocha HPLC ọkọlọtọ C18. Mgbasawanye elu a na-eme n'ihi na peptide dị ka ọtụtụ ndị na-atụgharị nwayọọ nwayọọ na-atụgharị n'usoro mkpanaka, ma ọ bụ n'ihi na usoro hydrophobic na-agbakọta na akụkụ nke kọlụm guzoro. Na-enweghị orthogonal mass spectrometry, A na-atụgharịkarị ọnụ ọnụ elu ndị a kewara ekewa dị ka ndakpọ ndakpọ kama ịgbanwe nha nhata..

4. Protocol nkwado akwadoro: Mwepu aka AI-ruo-Bench na-emebi ihe

Iji mebie amụma mgbakọ na mwepụ nke anụ ahụ, CDMO ga-enwerịrị ike iji usoro sịntetik pụrụ iche na ụlọ njirimara nyocha.

Ntinye usoro nke raw AI

Enwere ike CDMO tupu enyocha ihe egwu mkpokọta dị elu? ► Tinye Pseudoprolines / Isoacyl Peptides Multi-Disulfide Map? ► Otu ndị na-echebe Orthogonal (Trt/Acm/Mmt) Hydrophobicity dị elu? ► PEGylated Solubilizing Handles Synthesis & Nkà na ụzụ nyocha usoro n'ime ahịrị (PAT) Real-Time Fmoc Deprotection UV Monitoring Micro-Cleavage LC-MS Inter-Step Checks Orthogonal Analytical Characterization Suite.

1. RP-HPLC & ESI-MS / MALDI-TOF (Mass & Ịdị ọcha)
2. Dichroism okirikiri (CD) Spectroscopy (Ihe owuwu nke abụọ)
3. Mgbasa ọkụ dị egwu (DLS) (Nyocha monomeric)
4. Nkọwa nke Ellman & Ellman-LC-MS (Njikọta Disulfide)

Strategy Synthesis dị elu maka usoro AI siri ike

Mgbe usoro emebere AI na-akpalite ọnụ ụzọ ịkpachara anya n'oge triage tupu njikọ, CDMO nwere ahụmahụ na-etinye atụmatụ kemịkalụ ahaziri ahazi:

1. Pseudoproline dipeptides: Fanye X aa-Ser, X aa-Thr, ma ọ bụ X aa-Cys oxazolidine dipeptides ọ bụla fọdụrụnụ 5-6 iji mebie usoro nke abụọ β-ibé n'oge resin elongation..
2. Teknụzụ Isoacyl Peptide: Tụgharịa peptide bond ruo nwa oge ka ọ bụrụ njikọ ester (O-N acyl mgbanwe). Njikọ ester na-agbaji nchịkọta β-ibé n'oge njikọ; mkpughe na-esote na pH na-anọpụ iche 7.4 ihe nchekwa na-akpalite ngwa ngwa, Mbugharị acyl quantitative O-to-N iji weghachi ọkpụkpụ azụ amide nke ala.
3. Otu ndị na-echebe Orthogonal Disulfide: Jiri otu ichekwa orthogonal-dị ka Tril (Trt), Acetamidomethyl (Acm), na monometoxytril (Mmt)- ịmanye nzọụkwụ nzọụkwụ, Nhazi nke njikọ disulfide na-eduzi kama ịdabere na ikuku oxidation thermodynamic.
4. Mwepụta amụma amụma tupu synthesis: CDMO dị elu na-eji ụdị amụma amụma tupu synthesis iji kwalite njupụta resin loading, họrọ resins dabere na PEG dị ala (eg., ChemMatrix), ma mezie okpomoku eruba-njikọta okpomọkụ dynamically.

Orthogonal Analytical Validation Suite

5. Akwụkwọ egwuregwu arụ ọrụ: Na-eme ihe aka CDMO na-aga nke ọma

Iji rụọ ọrụ ntinye peptide AI, R&Ndị otu D kwesịrị ịmalite usoro ntinye aka nke usoro 5 ahaziri ahazi.

Nzọụkwụ 1: Mbupu Ngwungwu Nhazi Mgbakọ (PDB, NA-ebu ọnụ, JSON, Akara)

Nzọụkwụ 2: Tinye na Silico Triage Filter (GRAVY, pI, CamSol, TANGO) Nzọụkwụ 3: Nyocha nka nka CDMO & Nzọụkwụ Nlele Amụma 4: Synthesis pilot & Usoro nchịkwa nyocha usoro n'ime ahịrị 5: Mwepụta nyocha zuru oke & Asambodo QC kwadoro

Nzọụkwụ 1: Bupụ ngwugwu ngwungwu dijitalụ zuru oke

Chịkọta nsonaazụ mgbakọ niile-gụnyere faịlụ nhazi PDB, Usoro FASTA, ụdị provenance JSONs, na ihe fọrọ nke nta ka ọ bụrụ pLDDT arrays—n'ime otu ebe nchekwa nrubeisi.

Nzọụkwụ 2: Mee na nyocha nke Silico Triage

Wepụta ndị na-aga ime nzacha na-eji GRAVY, pI, CamSol, na iwu TANGO. Wepụ ihe ndị na-abụghị synthesizable na nkọwapụta ndị na-aga oke ala nwere mgbanwe kemịkalụ a rịọrọ (eg., mkpado solubilizing, N-terminal acetylation).

Nzọụkwụ 3: Nyochaa ike CDMO na atụmatụ Chemistry

Nyefee ngwungwu a nzacha n'aka onye mmekọ CDMO gị. Nyocha otu injinịa njikọ CDMO:

• Nhọrọ resin (Polystyrene vs. PEG-ChemMatrix).
• Ngwakọta kemistri (Ntụpụ ụkwụ, DIC/Oxyma, ma ọ bụ PyBOP).
• Atụmatụ nchebe maka motifs siri ike.

Nzọụkwụ 4: Nchịkọta Ọgụgụ Pilot nwere njikwa usoro

Maka akwụkwọ akụkọ de novo scaffolds, mee obere njikọ pilot (1-5 mg) na-egosipụta ezigbo nlele UV nke Fmoc deprotection kinetics na nyocha micro-cleavage LC-MS tupu mmepụta nnukwu..

Nzọụkwụ 5: Mwepụta QC nyocha yana ngwugwu ime ụlọ dị ọcha

Nyochaa ihe ikpeazụ megide ụlọ nkwado orthogonal. Gbaa mbọ hụ na a na-ahazi peptides dị ọcha nke ezubere maka omenala cell ma ọ bụ ụdị preclinical na klaasị 100 gburugburu ultra-adịghị ọcha iji kwe nkwa mmetọ endotoxin efu.

Mmekọrịta ya na CDMO pụrụ iche maka Peptides emebere AI

Dị ka generative AI ụdị na-aga n'ihu na-agbasawanye ọdịdị ọdịdị nke peptides ọgwụgwọ, ihe ịga nke ọma n'ikpeazụ dabere na ogbugbu anụ ahụ nke kemịkalụ sịntetik. Ebe ndị na-ebubata ihe n'ozuzu na-ewere peptides omenala dị ka ihe katalọgụ ngwa ahịa, AI siri ike chọrọ onye mmekọ CDMO pụrụ iche nke nwere teknụzụ njikọ dị elu, pre-synthesis feasibility nzacha, yana njikwa mma siri ike.

Mgbe ị na-ahọrọ onye na-emepụta ihe maka usoro AI haziri, na-enyocha ike ikpo okwu-dị ka ịnweta nnukwu ụlọ ndozi mgbanwe, ụlọ ọcha ultra-sterile, na nhọrọ ọnụọgụ elu na-agbanwe agbanwe - na-ahụ na atụmatụ mgbakọ na mwepụ na-agbanwe n'enweghị nsogbu n'ime nkwado anụ ahụ. R&Ndị otu D na-achọ ijikọ imewe dijitalụ site na iji nyocha ụlọ nyocha nwere ike ịkpọtụrụ nyiwe pụrụ iche dị ka MOL Changes maka. omenala peptide njikọ ọrụ yana nleba anya nleba anya nka nke ahaziri iji mebie aka AI-to-bench.

Nyochaa ike nka nka: Ka inyochaa pọtụfoliyo onye ndoro-ndoro mgbako gị megide oke nnwekọrịta ike ime, kpọtụrụ ndị otu teknụzụ MOL Changes maka nyocha tupu njikọ zuru oke.

Xiaoxia Chen

Ọgwụ ọhụrụ R&D nka nka Ọkachamara isi: Nchọpụta ebumnuche, nhazi-mmekọrịta ọrụ (SAR) nyocha, peptide-ọgwụ conjugates (Ndị PDC), na mmepe nke mgbochi ịka nká na metabolic peptides.

Banyere Onye dere ya Ozi kacha ọhụrụ

Profaịlụ: Xiaoxia Chen eduzila nchọpụta mmalite na nyocha nke ọma maka ọtụtụ ọgwụ peptide nke metabolic na etuto ezubere iche.. Ọ bụghị naanị na ọ maara nke ọma na nyocha ụlọ akwụkwọ peptide dị elu kamakwa ọ makwara nke ọma n'iji usoro mgbakọ na mwepụ na-enyere AI aka maka imewe usoro peptide de novo.. Ugbu a, ọ na-eduga otu ndị raara onwe ha nye nyocha miri emi na mmepe nke agonists multifunctional ọgbọ na-abịa (dị ka dual- ma ọ bụ peptides na-ebelata abụba ebumnobi okpukpu atọ) na anụ ahụ na-arụsi ọrụ ike nke ukwuu-ndozi peptides.

• Ogo nke ndị na-eweta Peptide na usoro ọchịchị 2026年10月8日
• Ndepụta ihe nleba anya na-aga n'ihu nke Peptide mgbe ire ahịa JPT gasịrị 2026年10月7日
• AI na Peptide dị ọcha: Ebe Ọ Na-enyere Aka n'ezie 2026年10月7日
• Mpempe akwụkwọ na-arụ ọrụ maka nchọpụta Peptide 2026年10月6日
• Iwu FDA NAM: Ntuziaka ngwugwu Peptide CMC 2026年10月6日

Achọpụtara eziokwu & Ntuziaka ndezi

Usoro inyocha eziokwu anyị

Anyị na-ebute izi ezi na iguzosi ike n'ezi ihe na ọdịnaya anyị ụzọ. Nke a bụ otu anyị si edobe ụkpụrụ dị elu:

1. Nyocha ọkachamara: Ndị ọkachamara gbasara ihe na-enyocha akụkọ niile.
2. Nkwado isi mmalite: Enwere ntụkwasị obi na-akwado ozi, isi mmalite ọhụrụ.
3. nghọta: Anyị na-ehota n'ụzọ doro anya ma na-ekpughe esemokwu ndị nwere ike ime.

Nyochaa ya bụ: Ndị ọkachamara Okwu

Ụlọ nyocha anyị

Ndị ọkachamara nwere ahụmahụ na-enyocha nke ọma ọdịnaya anyị iji hụ na izi ezi na mkpa.

• Ndị ọkachamara ruru eru: A na-enyocha akụkọ ọ bụla site n'aka ndị ọkachamara nwere ihe ọmụma gbasara mpaghara.
• Ntụle ọhụụ: Anyị na-etinye nyocha kachasị ọhụrụ, usoro, na ụkpụrụ.
• Nkwenye na Ogo: Ndị na-enyocha ihe na-eme ka o doo anya, ziri ezi, na izu oke.

Chọọ akara ndị ọkachamara nyochara ka ị gụọ ọdịnaya ị nwere ike ịtụkwasị obi.